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Abstract
Objective: To investigate the expression of pancreatic microRNAs (miRNAs) during the period of perinatal beta-cell
expansion and maturation in rats, determine the localization of these miRNAs and perform a pathway analysis with
predicted target mRNAs expressed in perinatal pancreas.
Research Design and Methods: RNA was extracted from whole pancreas at embryonic day 20 (E20), on the day of birth (P0)
and two days after birth (P2) and hybridized to miRNA microarrays. Differentially expressed miRNAs were verified by
northern blotting and their pancreatic localization determined by in situ hybridization. Pathway analysis was done using
regulated sets of mRNAs predicted as targets of the miRNAs. Possible target genes were tested using reporter-gene analysis
in INS-1E cells.
Results: Nine miRNAs were differentially expressed perinatally, seven were confirmed to be regulated at the level of the
mature miRNA. The localization studies showed endocrine localization of six of these miRNAs (miR-21, -23a, -29a, -125b-5p,
-376b-3p and -451), and all were expressed in exocrine cells at one time point at least. Pathways involving metabolic
processes, terpenoid and sterol metabolism were selectively affected by concomitant regulation by miRNAs and mRNAs,
and Srebf1 was validated as a target of miR-21.
Conclusions: The findings suggest that miRNAs are involved in the functional maturation of pancreatic exocrine and
endocrine tissue following birth. Pathway analysis of target genes identify changes in sterol metabolism around birth as
being selectively affected by differential miRNA expression during this period.
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Introduction
MicroRNAs (miRNAs) are small, single-stranded non-coding
RNA molecules involved in post-transcriptional control of gene-
expression of a wide number of genes. MiRNAs align and bind
especially to 39UTR sequences of their target genes and initiate
either mRNA degradation or translational repression, resulting in
reduced protein levels [1–3].
MiRNAs have been found to regulate many animal develop-
mental events such as proliferation, differentiation and apoptosis
[4]. Development of pancreas and islets of Langerhans is highly
dependent on developmental timing controlling specification,
neogenesis, proliferation and differentiation of individual cell
types [5]. Removal of endogenous miRNAs at different embryonic
time-points using Dicer(flox/flox) mice illustrate that miRNAs indeed
are involved in the fetal development of pancreas, most notably
the beta-cell lineage [6].
Numerous miRNAs have been reported to have roles in
pancreatic beta-cells: MiR-124a targeting Foxa2 [7,8] and miR-9
controlling insulin exocytosis via its target Onecut-2 [9]. MiR-375 is
one of few miRNAs (along with miR-7) expressed mainly in adult
islets and only marginally elsewhere [10–13], and controls a cluster
of genes regulating cellular growth and proliferation, evident from
studies of miR-375(2/2) mice, which are hyperglycemic and have
decreased beta-cell mass [11]. Thus, miRNAs have important
functions in mature beta-cells and for fetal development of beta-cells.
A burst of beta-cell replication and maturation takes place in the
perinatal period [14–16]. The mechanisms regulating perinatal
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gene expression have not been described in details; and the
miRNA profile of late developmental events in the pancreas has
not been determined. The present study investigates the expression
patterns of pancreatic miRNAs during the period of perinatal
beta-cell expansion and maturation to identify sets of differentially
regulated miRNAs. Subsequently, we determine the anatomical
localization of these miRNAs. Additionally, the current miRNA
expression profile and a corresponding mRNA expression profile
from the same samples was used to investigate possible down-
stream target pathways of the differentially regulated miRNAs.
Materials and Methods
Ethics statement
All studies were conducted in accordance with institutional
guidelines and approved by the Danish Animal Experiments
Inspectorate. Permit ID: 2008-561-1515.
Tissue-samples
Female Wistar rats, 10–11 weeks, were time-mated at Taconic,
Denmark and transferred to local facilities one week prior to
experiments. Animals had free access to food and water and were
kept on a 12 hr light–12 hr dark cycle. The rats were killed at
gestational day 20 (E20), immediately after birth (P0) or two days
after birth (P2), and the offspring were decapitated. Pancreata
were excised and placed in cold TRI Reagent (Sigma-Aldrich, St.
Louis, MO) for RNA extraction. This was repeated in three
independent experiments. Separately, protein lysates from pan-
creata were prepared using RIPA-buffer with a protease inhibitor
cocktail and Tissue-LyserII (Qiagen, Copenhagen, Denmark).
RNA extraction, qualification and sample preparation
Total RNA was extracted according to manufacturer’s
recommendations. RNA quality was measured using 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
Samples with a 28S/18S RNA ratio .2 and RNA integrity
number .7 were used for arrays. Three biologically different
RNA pools were generated for each time point by combining an
equal amount of RNA from 3–5 offspring from each dam. A
common reference pool was generated by combining the three
biologically different RNA pools from all three time points.
MicroRNA array analysis
RNA (1 mg) from each of the three biologically different, pooled
samples and common reference were labeled with Hy3 and Hy5
respectively using miRCURY LNA Labeling Kit (Exiqon,
Vedbaek, Denmark). Internal control synthetic Spike-in probes
(Exiqon) were added to each labeling reaction. Labeling swaps
were performed for technical duplicates of each sample. Labeled
RNA was hybridized to miRCURY LNA microRNA Arrays
ver.8.1 (Exiqon) in a HS400-Pro hybridization station (Tecan,
Gro¨dig, Austria). This array comprises probes for miRNA
described in the miRBase 8.1 release of the miRNA registry
(http://www.mirbase.org/) (462 human, 340 murine and 234 rat
miRNAs).
Data processing and analysis
Microarrays were scanned on an ArrayWoRx CCD-based
scanner (Applied Precision, Issaquah, WA, USA), and analyzed
using ImaGene and GeneSight software (Biodiscovery, Los
Angeles, CA, USA). Data were normalized within arrays using
intensity-dependent global normalization (LOWESS). The ratio
between sample and reference was calculated in addition to the
difference between the log2 transformed sample and reference.
Quality of the data was assessed by plotting normalized signals of
Hy3 against Hy5 and evaluating Spike-in controls. Slides showing
linear labeling were included in the statistical analysis. Hence,
sample 3 of P0 was rejected. Data with signal intensities below 25
were discarded. Statistical analysis was performed using the
TM4:MeV software package [17] and differentially expressed
miRNA were identified using one-way ANOVA (cut-off p,0.01).
Only miRNAs with greater than 1.5-fold increase or decrease in
expression at any time point were used for further analysis.
Hierarchical gene-tree clustering analysis was performed by
TM4:MeV using Euclidean distance and average linkage.
MIAME compliant miRNA array data have been deposited in
Array Express under the accession number E-MTAB-594.
Northern blotting: Total perinatal or INS-1E cell RNA (5 mg) was
resolved in 15% TBE-Urea gels (Invitrogen, Novato, CA, USA),
photographed and blotted to positive nylon membranes (Qbio-
gene, Montre´al, Canada). Complementary locked nucleic acid
(LNA) probes (Exiqon) for mature miRNAs were end-labeled with
[c-32P]dATP (Perkin Elmer, Waltham, MA, USA). Hybridization
was performed using the ULTRAhyb-Oligo protocol (Ambion,
Foster City, CA, USA).
In situ hybridization (ISH)
Pancreata excised at E20, P0 or P2 were formalin-fixed and
paraffin-embedded. For each time-point 3–4 different pancreata
and 2–3 sections per miRNA were hybridized and studied.
Sections were denatured 10 min at 42uC in 2.5 mU/ml Proteinase
K (Roche, Hvidovre, Denmark), incubated 5 min in 4%
paraformaldehyde, acetylated 10 min in 0.1 M triethanolamine
pH 8.0/0.25% acetic anhydride and prehybridized for 1 hr at 22–
25uC below probe Tm in hybridization mix (50% formamide/5x
SSC/0.5 mg/ml yeast tRNA/1x Denhardt’s solution supplement-
ed with 9.2 mM citric acid if hybridization temperature was above
55uC). Complementary LNA probes (Exiqon) were DIG-labeled
using DIG Oligonucleotide Tailing Kit 2nd Generation (Roche)
according to manufacturer’s recommendations. 2.5 pmol DIG-
labeled probes were added to hybridization mix, heated to 90uC
then iced, applied to each section and hybridized overnight at 22–
25uC below probe Tm. Sections were washed at 12–15uC below
probe Tm in decreasing SSC concentrations and incubated
15 min at 37uC in 20 mg/ml RNase A. For immunostaining
sections were incubated 2 hr in 1:100 anti-Digoxigenin-AP
(Roche), Vulcan Fast Red was applied and nuclei were
counterstained with Haematoxylin Carazzi. Sections were mount-
ed from xylene and imaged on a Leica DM 4000 B using Leica
Application Suite software. Negative controls included sections
without probe and with scrambled control probe (Exiqon) that
bear no homology to any known miRNA sequence.
In silico functional analysis
MiRanda (Microcosm at mirbase.org) [18] was used to predict
mRNA targets of differentially regulated miRNAs. This search
retrieved 728–994 predicted mRNA targets for each of the
differentially regulated miRNAs. MessengerRNAs expressed in
perinatal rat pancreas and regulated more than 2-fold from E20 to
P2 were extracted. This dataset was based on Affymetrix array
hybridization of the same samples as those used for miRNA array
hybridizations (L.W. Gaarn and J.H. Nielsen, unpublished data).
Comparison of miRanda predicted mRNA targets and differen-
tially expressed Affymetrix gene-sets was performed using Venn
diagrams [19]. Biological pathways were identified using Gene
Ontology [20] and KEGG [21] terms and GeneCodis 2.0 software
[22]. Default settings were used for GeneCodis 2.0 with p-values
adjusted with the method of Hochberg and Benjamini [23].
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Cell culture and nucleofection
INS-1E cells (gift from Claes Wollheim, Geneva, Switzerland)
were cultured as described previously [24]. 4?106 cells were
nucleofected with miR-21 and/or miR-29a LNA knock-down, or
scrambled LNA oligonucleotide (Exiqon) using an Amaxa
nucleofector (Lonza, Copenhagen, Denmark). Transfection effi-
ciency was approximately 70%. Cells were harvested for RNA and
protein 48 hr after transfection using TRI Reagent, or cells were
trypsinized, counted and extracted for cholesterol.
Real-time RT-Q-PCR: Complementary DNA was synthesized
from 1 mg RNA using iScript (BioRad, Copenhagen, Denmark)
following manufacturer’s recommendations. Q-PCR was per-
formed using SYBR Green with melting curve detection on a
Roche LightCycler instrument. For INS-1E TfIIB and for
perinatal pancreas Rpl13alpha was used for normalization
(described in [25], L.W. Gaarn and J.H. Nielsen, unpublished
data). MiR-21 Q-PCR was performed on stem-loop primed cDNA
according to [26] with TfIIB reverse primer present in the gene-
specific cDNA synthesis. Oligonucleotide sequences used are listed
in Table S3.
Western blotting
Proteins (20 mg) were separated on 12% acrylamide gels, blotted
to PVDF-membranes and Ponceau stained. After blocking
membranes were incubated with antibodies for SREBF1 (Santa
Cruz, sc-8984), SQLE (Santa Cruz, sc-49754), MnSOD (Stress-
gen, sod-111) or beta-actin (Abcam, A6276). As loading controls
MnSOD was used on perinatal blots and beta-actin was used for
cell culture extracts. HRP-conjugated secondary antibodies
(DAKO, Glostrup, Denmark) and enhanced chemiluminescence
(Pierce, VWR, Herlev, Denmark) were used for visualization.
Reporter gene analysis
Oligonucleotides with predicted miRNA binding sites or 2 base
mutated binding sites (in the seed sequence) were annealed,
phosphorylated and cloned into pGL4.13 (Promega, Nacka,
Sweden) in the 39UTR of the luc2 gene (using FseI/XbaI).
Constructs with perfect complementarity to miR-21 (‘Perfect’) and
this sequence scrambled (‘Scr’) were made as controls. All sequences
were checked for introduction of other miRNA binding sites, and if
this occurred in mutant constructs, other bases were changed to
avoid this (Table S3). Resulting clones were sequenced, purified and
used for transfection using Lipofectamine 2000 (Invitrogen) of INS-
1E cells. Reporter constructs were cotransfected with pRL
(Promega) to correct for differences in transfection efficiencies.
Endogenous miR-21 was inhibited with 25 pmol/well antisense
LNA-21 (Exiqon) cotransfected with reporter vectors (scrambled
LNA oligonucleotides served as negative control). Twenty-four
hours later cells were lysed and luciferase activities measured using
the Dual-luciferase assay (Promega). To facilitate comparisons of
individual experiments the mean of the pGL4.13 vector was
adjusted to the same level in all 4 experiments and the data pooled.
The resulting means are in arbitrary values.
Cholesterol determination
Cells were extracted using chloroform:isopropanol:NP-40
(7:11:0,1) and total cholesterol determined using the Cholesterol
Quantitation Kit according to instructions from manufacturer
(MBL International, Nordic Biosite, Copenhagen, Denmark).
Statistics
ANOVA was used to test for differentially expressed miRNAs,
using a significance level of 0.01. The significance level for FDR
adjusted p-values when using Gene-Codis was 0.05. In other
experiments t-test was used to compare treatments, with a
significance level of 0.05.
Results
Identification of miRNAs in perinatal rat pancreas on
embryonic day 20, postnatal day 0 and postnatal day 2
This study investigated miRNAs expressed in the perinatal rat
pancreas on embryonic day 20 (E20), postnatal days 0 and 2 (P0
and P2). The LNA-oligonucleotide array identified the presence of
108 known rat miRNAs (for complete list and heat-map see
Fig.S1). A number of miRNAs are expressed at high intensities
throughout the perinatal period, but are not regulated from E20 to
P2 (listed with decreasing expression level: miR-298, -494, -292-
5p, -503, -290, -320, let-7c, -327, -185, let-7b and let-7a).
We identified 9 miRNAs that were differentially expressed and
showed a more than 1.5-fold increase or decrease in expression
level across the different time points from E20 to P2. These were:
miR-21, -23a, -29a, -125b-5p, -141, -376a, -376b-3p, -341 and
-451 (Fig. 1A). The intensities are in the middle range except for
miR-341, which is expressed at a low level (data not shown).
To group miRNA with similar expression profiles, gene-tree
clustering analysis was performed (Fig. 1B), which identified 4
specific expression patterns. Cluster I and II consisted of miR-29a
and miR-21, and miR-125b-5p and miR-23a, respectively, and
showed an increased expression at P0 and P2 compared to E20.
Cluster III included miR-141 and miR-376a and had increased
expression at P0 and then a decreased expression at P2 compared
to E20. Cluster IV included miR-451, -341 and -376b-3p and
their expression decreased from E20 to P2.
Validation of microarray hybridizations using northern
blotting
We used northern blot analysis to verify the array results and to
visualize the presence of pri-, pre- and mature miRNA (Fig. 2),
which revealed mature miRNA for all the analyzed miRNA
except miR-341. Because only pre-miR-341 was detectable by
northern blotting, it was eliminated from further analysis (for
images of whole blots see Fig.S2). Quantification of the mature
miRNA bands for the remaining miRNAs showed a similar
expression pattern as the array data and hence verified the array
results. The exeptions were miR-376a, which show a similar
expression pattern as miR-376b-3p; and miR-23a, whose levels
did not significantly rise from E20 to P2 (Table S1). We detected
two mature species for miR-451, which may be due to its unusual
structure where the mature miRNA extends into the loop
sequence [27]. INS-1E cells were used as a control for miRNA
expression in beta-cells and all miRNAs could be detected in INS-
1E cells except miR-376b-3p, -376a and -451. Interestingly, INS-
1E cells contained precursor miRNA species for miR-451 and
miR-376b-3p, but absence of mature miRNAs (Fig.S2). Thus, 3
out of the 9 miRNAs differentially regulated in our data-set show
difference between regulation at precursor and mature miRNA
levels either in pancreas or in INS-1E cells, suggesting cell type
specific or temporal regulation of miRNA processing.
Localization of differentially expressed miRNAs in
perinatal rat pancreas
ISH was used in order to identify the localization of the miRNA
in pancreas according to exocrine or endocrine tissue (Table 1).
Northern blots (Fig. 2) showed that miR-21, -29a, -23a, -141 and
-125b-5p all were expressed in INS-1E cells and therefore
Regulated miRNAs in Perinatal Rat Pancreas
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expected to be localized to endocrine tissue. ISH confirmed the
localization to endocrine and exocrine tissue (Fig. 3 and Fig.S3);
however, miR-141 was only weakly expressed in endocrine cells
and predominantly found at P0 and P2 in exocrine cells.
Interestingly, at E20 most of the miRNAs (except miR-141) were
expressed in both exocrine and endocrine tissue. MiR-29a was
expressed in acinar and islet cells at E20 and changed to being
mostly endocrine at P0 and P2. Localization of miR-21 changed
from equally exocrine and endocrine at E20 to mostly exocrine
expression at P2. MiR-23a and miR-125b-5p were mostly acinar,
Figure 1. Microarray analysis of differentially expressed
miRNAs in the perinatal rat pancreas. A. Heat-map showing
hierarchical gene-tree and sample clusters of the 9 miRNAs that were
significantly (p,0.01) regulated more than 1.5-fold. Sample to reference
ratio for the different biological samples are shown. (Complete heat-
map is shown in Fig.S1). B. Expression pattern of the miRNAs based on
the gene-tree clustering. Shown is the ratio compared to E20 of the
mean of sample to reference ratio with SD.
doi:10.1371/journal.pone.0025997.g001
Figure 2. Validation of miRNA expression using northern
blotting. Northern blots of the mature miRNAs are shown. Total
RNA from INS-1E cells were used as a control for miRNA expression in
beta-cells. Quantification of the mature miRNA bands is shown below
each gel as the ratio of signal intensities compared to E20. (Images of
whole gels are shown in Fig.S2).
doi:10.1371/journal.pone.0025997.g002
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and expressed at a lower level in islets. MiR-376a, -376b-3p and
-451 were localized to exocrine cells (miR-451 only at E20). Even
though miR-376a, -376b-3p and -451 were not detected in INS-
1E cells, they were detected in some islet cells at E20 and P0.
Generally, the expression patterns identified in the array and
northern hybridizations were also detected using ISH.
Predicted target mRNAs of differentially regulated
miRNAs
Prediction of miRNA target mRNAs was carried out using the
algorithm miRanda [28], which predicted hundreds of potential
targets for each miRNA. We limited the search to predicted
mRNA targets, which were expressed and regulated in perinatal
pancreas. 1057 genes were found to be differentially regulated in
rat pancreas between E20 and P2, and 778 were fully annotated
(L.W. Gaarn and J.H. Nielsen, unpublished data) of which 126
genes were potential miRNA targets in perinatal pancreas (Table
S4). There were no mRNAs, which were targets of all differentially
expressed miRNAs (Table S4). Since the list only contained
miRNA targets regulated at the mRNA level it favored miRNAs
altering mRNA transcript levels.
Predicted biological functions of target mRNAs of
regulated miRNAs
Pathway analysis using the 126 perinatally regulated genes that
were also potential miRNA targets showed that the most
significant Biological Processes (GO:BP) category (using GeneCo-
dis ver.2 [22,29]) was ‘metabolic processes’ containing 16 genes.
More specific categories were ‘response to hypoxia’, ‘lipid
metabolic process’, ‘cholesterol metabolic process’, ‘cholesterol
biosynthetic process’, ‘steroid metabolic process’, ‘isoprenoid or
terpenoid biosynthetic process’ and ‘fatty acid oxidation’ each
containing from 3–5 genes (Table 2 and Table S2). The identified
KEGG pathways were ‘Valine, leucine and isoleucine degradation
Table 1. Exocrine and endocrine localization and approximate levels of differentially regulated miRNAs in perinatal rat pancreas at
E20, P0 and P2 determined using ISH.
MiRNA E20 P0 P2
Exocrine Endocrine Exocrine Endocrine Exocrine Endocrine
miR-21 + + (+) + ++ (+)
miR-29a + + + ++ + ++
miR-125b-5p ++ + ++ + + +
miR-23a ++ ++ ++ + ++ +
miR-376a + (+) ++ (+) + 2
miR-141 2 2 + 2 + (+)
miR-376b-3p ++ (+) + (+) 2 2
miR-451 ++ + 2 2 2 2
‘+’ denotes miRNA present, ‘++’ denotes higher amount of miRNA present, (+) denotes presence of miRNA in some cells, ‘2’ denotes no miRNA present. MiR-21 showed
heterogeneous staining between pancreata.
doi:10.1371/journal.pone.0025997.t001
Figure 3. Localization of miR-21 and miR-29a in perintal rat pancreas at E20, P0 and P2 by in situ hybridization. Negative control:
scrambled probe. Magnification: 4006.
doi:10.1371/journal.pone.0025997.g003
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and synthesis’, ‘short chain fatty acid metabolism’, ‘pyruvate
metabolism’ and ‘biosynthesis of steroids’. These pathways contain
to a large degree the same mRNAs as the significant GO
categories (Table S2).
Thus, pathways related to lipid or specifically sterol synthesis,
metabolism or degradation resulted from the pathway analysis.
SREBF1, which is a key transcriptional regulator for genes
involved in the early (isoprenoid biosynthesis) and late steps of
cholesterol synthesis (Fig. 4) is a predicted target of miR-21. In
addition, SQLE (squalene epoxidase), which catalyzes a rate-
limiting step in sterol synthesis and mitochondrial ACAT1 (acetyl-
coenzyme A acetyltransferase 1), which catalyzes the first step of
isoprenoid biosynthesis, are also predicted targets of miR-21.
Many genes involved in both early and late steps of cholesterol
synthesis decrease their mRNA expression dramatically after birth
(Fig. 5A, B). Among these are a number of predicted target
mRNAs, such as Acat1, Hmgcs1, Hmgcr, Pmvk, Idi1, Ggps1, Sqle,
Nsdhl, Soat2, Cel, Hdlbp, Srebf1 (Fig. 5A, B, Fig. 4, Table S4).
Table 2. Selected biological processes in which predicted miRNA target genes are over-represented in perinatal rat pancreas
according to Gene Ontology categories.
Annotations Number of genes Corrected p-value Genes MiRNAs
Lipid metabolic process 5 0.005 Soat1, Hdlbp, Acaca,
Crot, Srebf1
miR-141/125b-5p,miR-451/125b-5p,
miR-376a/376b-3p,miR-376b-3p,miR-21
Cholesterol metabolic process 5 1.7E-04 Soat1, Hdlbp, Sqle,
Srebf1, Nsdhl
miR-141/125b-5p,miR-451/125b-5p,
miR-21,miR-21,miR-376a/376b-3p
Cholesterol biosynthetic process 4 2.1E-04 Hmgcs1, Hmgcs2,
Idi1, Nsdhl
miR-451,miR-21/376a/451,
miR-376a/451,miR-376a/376b-3p
Isoprenoid biosynthetic process 4 0.002 Hmgcs1, Hmgcs2,
Hmgcr, Idi1
miR-451,miR-21/376a/451,miR-29a,
miR-376a/451
Steroid metabolic process 3 0.02 Soat1, Hdlbp, Srebf1 miR-141/125b-5p,miR-451/125b-5p,miR-21
The order of the gene in the ‘Genes’ column corresponds to the order of the listed miRNA binding it in the ‘MiRNAs’ column. Where multiple miRNAs bind the same
mRNA these are separated by slashes. For a full list of significant biological processes containing predicted miRNA target genes please consult with Table S2. Full names
of genes may be found in Table S4 or in the legend to Figure 4 or Figure 5.
doi:10.1371/journal.pone.0025997.t002
Figure 4. Enzyme pathway of isoprenoid/terpenoid and sterol biosynthesis adapted from KEGG [21] with indication of predicted
target genes of regulated miRNAs in perinatal rat pancreas. SREBF1 targets are indicated with ‘#’ next to the name and are identified
through Bennett et al. (2008) and Seo et al. (2009) [48,49]. Abbreviations: Hmgcs1 (3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble),
Hmgcr (3-hydroxy-3-methylglutaryl-coA reductase), Mvk (mevalonate kinase), Pmvk (phosphomevalonate kinase), Mvd (mevalonate (diphospho)
decarboxylase), Idi1 (isopentenyl-diphosphate delta isomerase 1), Fdps (farnesyl diphosphate synthase), Ggps1 (geranylgeranyl pyrophosphate
synthetase), Fdft1 (farnesyl diphosphate farnesyl transferase 1), Lss (lanosterol synthase), Cyp51 (cytochrome P450, subfamily 51), Tm7sf2
(transmembrane 7 superfamily member 2), Sc4mol (sterol-C4-methyl oxidase-like), Nsdhl1 (NAD(P) dependent steroid dehydrogenase-like),
Hsd17b7(hydroxysteroid (17-beta) dehydrogenase 7), Hsdl2 (hydroxysteroid dehydrogenase like 2), Dhcr24 (24-dehydrocholesterol reductase), Ebp
(emopamil binding protein (sterol isomerase)), Sc5dl (sterol-C5-desaturase), Dhcr7 (7-dehydrocholesterol reductase), Soat1 (sterol O-acyltransferase 1),
Cel (cholesterol ester lipase), rno (rattus norvegicus), hsa (homo sapiens).
doi:10.1371/journal.pone.0025997.g004
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SREBF1 mRNA and protein levels in response to miR-21
levels
Expression of most of the mRNAs in the isoprenoid and sterol
synthesis pathway decreased between E20 and P0 (Fig. 5A, B).
SREBP1 mRNA and protein levels in the perinatal pancreas also
showed a decrease between E20 and P0 and an increase in miR-21
of which Srebf1 mRNA is a predicted target (Fig. 5C, D). Although
both mRNA and protein levels of SREBP1 decreased sharply
following miR-21 up-regulation at P0 (Fig. 5C, D), protein levels
rose again at P2, where miR-21 continues to be expressed. Clearly,
miR-21 cannot be the only factor controlling SREBP1 protein
levels; also dietary lipids, which are known to affect SREBP1 levels
and activity, change after birth.
To identify whether Srebf1 could be a true target mRNA of miR-
21 we introduced miR-21inhibitor (LNA-21) and control oligo-
nucleotides (LNA-scr) into INS-1E cells, and extracted RNA and
protein from these. MessengerRNA levels of Srebf1 increased by
about 30% after miR-21 knock-down (Fig. 5E). Also SREBP1
protein levels increased approximately 50% after miR-21 knock-
down compared with a LNA-scr (Fig. 5G, H). These data were
consistent with Srebf1 being a target gene of miR-21. We also
investigated whether mRNA and protein levels of SQLE changed
when miR-21 levels were modified; however, mRNA levels were
unaltered (data not shown) and we were unable to produce specific
western blots using the available commercial SQLE antibody.
Reporter-gene analysis of predicted miR-21 target genes
To validate the predicted miR-21 target sites in the 39UTR of
Srebf1, Acat1 and Sqle luciferase reporter vectors were constructed
(Fig. 6A). Wild type target reporter constructs were pair-wise
compared with mutant constructs in which 2 bases of the seed
sequence in the miRNA binding site were changed. In order to
validate the reporter assay a perfect miR-21 complementary target
site sequence clone (A-construct) and a scrambled miR-21 target
site sequence clone (B-construct) were transfected into INS-1E
cells, which express mature miR-21 (Fig. 2). The luciferase activity
of the ‘Perfect’ A-clone was lower than the ‘Scr’ B-clone
(p,0.0001)(Fig. 6B). The B-construct had increased activity
compared with pGL4.13, which could be due to destruction of a
negative regulatory signal by the cloned insertion. Mutation of the
miR-21 target site of Srebf1 led to an increased luciferase activity
(Fig. 6B, ‘C’ vs. ‘D’, p,0.0001). However, there were equal
activities of the Acat1 and Sqle target clones and their correspond-
ing mutant vectors (Fig. 6B, ‘E’ vs. ‘F’ and ‘G’ vs. ‘H’).
To test the direct responsiveness toward miR-21, miR-21
inhibitor (LNA-21) and negative control (LNA-scr) were co-
transfected with the reporter vectors (Fig. 6D, Fig. S4A, B). As
control pGL4.13, ‘Perfect’ and ‘Scr’ vectors were also compared
(Fig. 6C). Removal of miR-21 from pGL4.13 did not have any
effect indicating that this contains no endogenous miR-21 site.
There was a slight inhibitory action of LNA-scr when co-
transfected with pGL4.13 (Fig. 6C, ‘pGL4.13’ vs. ‘pGL4.13+
LNA-scr’). Co-transfection of miR-21 inhibitor caused a 3-fold
increase in the luciferase activity of the ‘Perfect’ binding site vector
(‘A+LNA-scr’ vs ‘A+LNA-21’, p,0.0001), demonstrating effective
inhibition of miR-21 by the LNA-oligonucleotide and confirming
the Q-PCR assay of miR-21 shown in Fig. 5F.
Inhibiting miR-21 increased luciferase activity of the Srebf1
target vector (Fig. 6D ‘C+LNA-21’ vs. ‘C+LNA-scr’, p,0.05),
demonstrating that the target site is functional, but the quantitative
effect of removing cellular miR-21 is small. Removing miR-21 had
no effect on the mutant Srebf1 target site construct.
Reporter-gene analysis of the predicted target sites of Acat1 and
Sqle were unable to confirm that these two predicted targets of
miR-21 were functional (Fig. 6 and Fig. 4A and 4B), which is
consistent with measurements of mRNA levels. The transfection
efficiency of the LNA-spiked oligonucleotides is about 50% in
INS-1E cells, whereas the plasmid transfections efficiency is 25%
(data not shown). Most cells transfected with reporter plasmids
were therefore also transfected with LNA-spiked oligonucleotides.
In summary, out of the three tested targets, Srebf1 was conclusively
found to be a functional target of miR-21.
Analysis of cholesterol levels
To determine whether the presence of multiple targets of miR-
21 and miR-29a (Fig. 4) along the cholesterol synthesis pathway
resulted in a cumulative effect on cholesterol levels, we extracted
and measured cholesterol in INS-1E cells nucleofected with
oligonucleotide inhibitors of miR-21 and miR-29a (LNA-21 and
LNA-29a) and negative control oligonucleotide (LNA-scr). Cells
with inhibited miR-29a alone or with miR-21 had increased total
cholesterol levels compared with LNA-scr (Fig. 6E, ‘LNA-scr’ vs.
‘LNA-29a’ or vs. ‘LNA-21+29a’, p,0.05). There was an
insignificant increase in cholesterol levels of cells treated with
miR-21 inhibitor. Thus, inhibition of miR-21 and miR-29a
simultaneously and miR-29a by itself increased total cholesterol
levels, showing that the increase of miR-21 and miR-29a following
birth is likely to functionally participate in the decrease of the
cholesterol synthesis pathway.
Discussion
This study represents the first characterization of miRNA
expression in perinatal rat pancreas. We have 1) Determined the
Figure 5. Correlations between mRNAs and miRNA-21 expression. Expression of mRNAs involved in isoprenoid (A) and cholesterol (B)
biosynthesis in perinatal rat pancreas based on data from micro-array hybridizations. Data are presented as relative to the hybridization signal at E20.
C. miR-21 and Srebf1 mRNA levels in perinatal rat pancreas (n = 3). Endogenous control: Rpl13alpha. D. Western blot of SREBF1 in perinatal rat
pancreas at E20, P0 and P2. Loading control: MnSOD. E. mRNA levels for Srebf1 following knock-down of miR-21 in INS-1E cells (LNA-21: Knock-down
of miR-21, LNA-scr: Scrambled control LNA, endogenous control: TfIIB). Data from 4 individual experiments each performed in duplicate
nucleofections, *: p,0.05. F. miR-21 levels in INS-1E cells nucleofected with either knock-down LNA-oligonucleotide directed against miR-21 (LNA-21)
or with a scrambled negative control LNA-oligonucleotide (LNA-scr). MiR-21 levels were determined using Q-PCR and are presented relative to the
endogenous control TfIIB. Data from 3 individual experiments each performed in duplicate nucleofections, ***: p,0.001. G and H. Protein levels of
SREBF1 following knock-down of miR-21 in INS-1E cells. Representative western blot of SREBF1 in INS-1E is shown in G and in panel H is shown the
quantification of 5 blots containing samples from 9 individual nucleofections. (LNA-21: Knock-down of miR-21, LNA-scr: Scrambled control LNA,
Loading control: beta-actin).*: p,0.05. Abbreviations: Hmgcs1 (3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)), Hmgcr (3-hydroxy-3-
methylglutaryl-coA reductase), Idi1 (isopentenyl-diphosphate delta isomerase 1), Mvk (mevalonate kinase), Mvd (mevalonate (diphospho)
decarboxylase), Fdps (farnesyl diphosphate synthase), Pmvk (phosphomevalonate kinase), Soat1 (sterol O-acyltransferase 1), Fdft1 (farnesyl
diphosphate farnesyl transferase 1), Lss (lanosterol synthase), Dhcr7 (7-dehydrocholesterol reductase), Dhcr24 (24-dehydrocholesterol reductase),
Cyp51 (cytochrome P450, subfamily 51), Tm7sf2 (transmembrane 7 superfamily member 2), Nsdhl1 (NAD(P) dependent steroid dehydrogenase-like),
Sc4mol (sterol-C4-methyl oxidase-like), Hsdl2 (hydroxysteroid dehydrogenase like 2), Ebp (emopamil binding protein (sterol isomerase)), Ggps1
(geranylgeranyl pyrophosphate synthetase).
doi:10.1371/journal.pone.0025997.g005
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miRNA profile of perinatal pancreas, which is undergoing large
structural and metabolic changes in the period around birth and
identified and validated 7 miRNAs regulated more than 1.5-fold
from E20 to P2; 2) Localized regulated miRNAs by ISH; 3)
Performed focused pathway analysis of pathways affected by
regulated miRNAs using predicted mRNA target genes also
regulated in perinatal pancreas; 4) Shown that biochemical
pathways relating to sterol and lipid biosynthesis and metabolism
are affected by the perinatally regulated miRNAs; 5) Validated
Srebf1 as target gene of miR-21 and shown an effect of miR-21 and
miR-29a on INS-1E beta-cell cholesterol levels.
These observations contribute to the understanding of the
structural and functional changes occurring in perinatal pancreas
and further our understanding of how beta-cells proliferate,
differentiate and functionally mature, as these are major events
taking place in pancreas around time of birth. The rate of beta-cell
proliferation in neonatal pancreas is approximately 10–30 fold
greater than in adult pancreas [15,30]. Furthermore, during the
perinatal period the structure of islets changes from small islets and
scattered beta-cells to more organized, mature islets. In rat
pancreas, there is a marked increase in amount of beta-cells
between E20 to P0 and further to P2 [15,30]. The function of the
pancreas also changes during this period, where there is a transition
from receiving nutrients via the placenta to ingestion of milk.
Seven miRNAs were differentially regulated more than 1.5-fold
in the perinatal pancreas. None of these were highly expressed and
Figure 6. Reporter-gene analysis of predicted target genes of miR-21 and their binding sites. A. Predicted binding sites in the Srebf1,
Acat1 and Sqle 39UTRs with suggested miR-21 binding. The p-values of the miRanda prediction algorithm for these three targets were: Srebf1:
p = 0.0006, Acat1: p = 0.0004 and Sqle: p = 0.001. B–E. Luciferase activities of reporter vectors normalized to pRL activity. B. Activities of target site and
mutant site reporter vectors together with activity of pGL4.13. (The key for clone names and their target site is: A: Perfect match for miR-21, B:
Scrambled miR-21 perfect match site, C: miR-21 Srebf1 site, D: miR-21 Srebf1 site with 2 bases mutated in seed sequence, E: miR-21 Acat1 site, F: miR-
21 Acat1 site with 2 bases mutated in seed sequence, G: miR-21 Sqle site with 2 bases mutated in seed sequence.) #: p,0.0001 vs. ‘A’ (‘Perfect’), *:
p,0.05 vs. ‘C’ (Srebf1). C. Luciferase activities after co-transfecting LNA-21 and LNA-scr with Perfect (‘A’) and Scrambled (‘B’) vectors, **: p,0.01 vs.
‘pGL4.13+LNA-21’, #: p,0.0001 vs. ‘A+LNA-scr’. D. Luciferase activities of the Srebf1 target site (‘C’) and the 2 base mutated vector (‘D’) with co-
transfection of LNA-21 and LNA-scr. #: p,0.0001 vs. ‘C’, *: p,0.05 vs. ‘C+LNA-21’. E. Total cholesterol levels of INS-1E cells following knock-down of
miR-21 and/or miR-29a in INS-1E cells (LNA-21: Knock-down of miR-21, LNA-29a: Knock-down of miR-29a, LNA-scr: Scrambled control LNA, Untransf:
Untransfected). *: p,0.05 vs. LNA-scr. The experiment was repeated 3 times.
doi:10.1371/journal.pone.0025997.g006
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the general fold regulation is quite low. However, miR-21 and
miR-29a were 2.5- and 4-fold increased. MiR-21 has been found
to be up-regulated in several studies of pancreas cancer, is
associated with a poor prognosis and generally increases cellular
proliferation [31–33]. MiR-21 up-regulation coincides with the
rise in beta-cell proliferation and could be a contributing factor to
this. ISH was used to assess miR-21 expression in human
pancreatic adenocarcinoma, where miR-21 expression was found
in malignant tissue but not in normal acinar tissue. In our ISH
study we localized miR-21 to be expressed in perinatal acinar cells
and in pancreatic islets, correlating well with the rapid
proliferation in exocrine and endocrine cells of postnatal pancreas.
MiR-29a has previously been recognized as a miRNA
increased in adipose tissue and skeletal muscle in diabetes
[34,35]. Here, miR-29a was expressed in exocrine and endocrine
pancreas with highest expression in islets, in line with findings
from adult pancreas [12]. MiR-29 family members are often
down-regulated in cancer and forced expression of miR-29a is
reported to reduce proliferation and invasiveness presumably via
CDC42 and p85alpha dependent up-regulation of p53 [36,37].
MiR-125b-5p [38] as well as miR-23a and miR-376a are up-
regulated in pancreatic cancer [32,39]. MiR-23a has been
reported to be expressed in endothelial cells [40], but our ISH
data do not reveal miR-23a expression in neither small nor large
vessels in perinatal pancreas. It should be noted that although our
results show the distribution of miRNAs between the exocrine
and the endocrine compartment of perinatal pancreas, they do
not reveal the specific localization of miRNAs within islets to i.e.
alpha or beta-cells.
In general, we observe a similar expression profile by northern
blotting as initially observed by array hybridizations. There are
three exceptions to this: First, array hybridization show that miR-
376a is increased at P0 compared with E20, whereas northern
blots showed a decrease in mature miR-376a at P0. Although ISH
is not quantitative this method confirmed the northern blots, since
we generally detected a lower signal of miR-376a at P0 and P2
than at E20. Secondly, array data showed differential regulation of
miR-341; however, the mature miR-341 species was not detected
on multiple northern blots, whereas high signal intensities were
observed for pri-miR-341 or pre-miR-341 (Fig.S2). Thus, the
LNA-modified oligo-arrays were accurate, but verification by
another method is necessary. We favored northern blotting over
Q-PCR, because the biologically inactive precursor species may be
co-amplified with the mature species when performing stem-loop
RT-PCR [41]. Third, the regulation of miR-23a measured using
northern blotting was below 1.5-fold change, but as it was slightly
increased also by northern blotting, we included it in the further
studies.
The mRNA expression profile of perinatal rat pancreas was
used in order to enrich the pathway analysis for genuine targets of
regulated miRNAs. This procedure focuses on miRNA targets
regulated at the mRNA level and disfavors miRNA-mRNA
interactions that primarily result in translational inhibition.
The pathway analysis identified cholesterol or lipid metabolism
as pathways selectively targeted by the perinatally regulated
miRNAs (Fig. 4). One of these is Srebf1 (or Srebp1), which together
with Srebf2 is responsible for activation of genes involved in
cholesterol and lipid metabolism, when exogenous cholesterol
levels are low. The miR-21 binding site of Srebf1 is rat specific;
however the human SREBF1 gene contains a binding site for miR-
29a, and this miRNA is also increased in islets at P0 and P2 and
has an effect on cholesterol levels. Thus, also human sterol
synthesis is predicted to be selectively targeted by the miRNAs
identified as being regulated from E20 to P2 in rat pancreas
(Fig. 4). Whether this miRNA expression pattern is conserved in
human fetal and newborn pancreas needs to be determined.
SREBP1 is important for regulation of glucose-stimulated insulin
secretion of adult beta-cells. Over-expression of SREBP1 decreases
glucose-stimulated insulin secretion, and SREBP1 is activated in
beta-cell gluco-lipotoxicity [42–44]. In the clonal INS-1E beta-
cells SREBP1 and miR-21 are co-expressed, however, co-
localization was not determined in perinatal beta-cells. Cholesterol
levels in pancreatic beta-cells are tightly regulated as too much
cholesterol will inhibit glucose-stimulated insulin secretion and
induce lipotoxicity, whereas too little cholesterol impairs mem-
brane fluidity and by this mechanism decreases insulin exocytosis
[45,46]. It is possible that up-regulation of miR-21 and/or miR-
29a in perinatal rat pancreas act through down-regulation of Srebf1
and other genes in the cholesterol synthesis pathway to fine-tune
cholesterol levels and promote functional maturation of beta-cells
following birth.
Whether the perinatal regulation of miR-21 and miR-29a is
present in other tissues remain to be investigated; however,
cholesterol synthesis of rat liver, intestines and brain decrease
sharply at the day of birth and synthesis rates then increase again
on postnatal day 2 [47], which is consistent with the mRNA and
miRNA expression pattern observed in pancreas.
The quantitative effect of miR-21 on Srebf1 was small as
determined from western blots and luciferase reporter assays.
However, we believe that our assays genuinely capture the effects
of these miRNAs, because we have shown effective inhibition of
miR-21 using LNA-modified oligonucleotides (Fig. 5F) and the
effects of the functional reporter assays on the Srebf1 target site
(Fig. 6B and D) mirror the effects of miR-21 on Srebf1 mRNA and
protein levels (Fig. 5E and H). It seems likely that these small
effects are functional given that we can increase cholesterol levels
by inhibiting miR-21 and miR-29a.
In conclusion, a comparison between the mRNA and the
miRNA expression pattern of perinatal pancreas showed that
regulated miRNAs selectively target cholesterol synthetic genes.
Specifically the up-regulated miR-21 mediated down-regulation of
Srebf1.
Supporting Information
Figure S1 Microarray analysis of miRNAs expressed in
the perinatal rat pancreas. Heat-map showing a hierarchical
gene-tree cluster of the 108 miRNAs that are expressed at E20, P0
and P2 with signal intensities .25.
(TIF)
Figure S2 Validation of miRNA expression using north-
ern blot. Whole images of northern blot membranes. The
mature miRNAs are marked with an arrow. E20 and P2 were
loaded in triplicates and P0 in duplicates. Total RNA from INS-
1E cells were used as a surrogate control for miRNA expression in
beta-cells.
(TIF)
Figure S3 Images from ISH sections stained for miR-21,
-29a, -451, -141, -376a, -376b-3p, -23a, -125b-5p and
corresponding scrambled control. Magnification: 4006.
(TIF)
Figure S4 Reporter-gene analysis of predicted target
sites in Acat1 and Sqle in response to exogenous miR-21.
A. Luciferase activities of the Acat1 target site (‘E’) and the 2 base
mutated vector (‘F’) with co-transfection of LNA-21 and LNA-scr.
*: p,0.05 vs. ‘E’, #: p,0.005 vs. ‘F+LNA-21’. B. Luciferase
activities of the Sqle target site (‘G’) and the 2 base mutated vector
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(‘H’) with co-transfection of LNA-21 and LNA-scr. Data are from
4 individual experiments each performed in duplicate transfec-
tions.
(TIF)
Table S1 Quantification of northern blots and compar-
ison with array hybridizations.
(DOC)
Table S2 Complete list of significant biological pro-
cesses containing predicted miRNA target genes. A. GO
categories B. KEGG categories.
(DOC)
Table S3 List of oligonucleotides used for Q-PCR and
for cloning miR-21 target reporter vectors.
(DOC)
Table S4 Predicted target mRNAs of differentially
expressed miRNAs. List of the common genes predicted by
Microcosm and regulated in the perinatal pancreas divided into
clusters according to shared miRNAs.
(DOC)
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